Literature DB >> 20332181

Drugs vs. ablation for the treatment of atrial fibrillation: the evidence supporting catheter ablation.

Isabelle Nault1, Shinsuke Miyazaki, Andrei Forclaz, Matthew Wright, Amir Jadidi, Pierre Jaïs, Mélèze Hocini, Michel Haïssaguerre.   

Abstract

Treatment strategy for atrial fibrillation (AF) is a controversial matter. Catheter ablation is increasingly being used to treat patients with AF, and recent studies have reported success rates >80% for paroxysmal AF and >70% for persistent AF. The purpose of this work is to review the evidence supporting catheter ablation and compare it with pharmacological treatment in the management of AF.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20332181     DOI： 10.1093/eurheartj/ehq079

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


  19 in total

1.  Clinical significance of the timing of early recurrence of atrial arrhythmia after pulmonary vein isolation: a two-institution clinical study.

Authors:  Yosuke Murase; Yasuya Inden; Hajime Imai; Seifuku Kyo; Satoshi Yanagisawa; Aya Fujii; Yusuke Sakamoto; Toshiro Tomomatsu; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

2.  Catheter ablation or surgery to eliminate longstanding persistent atrial fibrillation.

Authors:  Rajan L Shah; Junaid A B Zaman; Sanjiv M Narayan
Journal:  Int J Cardiol       Date:  2019-12-27       Impact factor: 4.164

Review 3.  Cardiac Resynchronization Therapy in Patients with Atrial Fibrillation - Worth the Effort?

Authors:  António M Ferreira; Pedro Carmo; Pedro Adragão
Journal:  J Atr Fibrillation       Date:  2012-04-14

4.  Monitoring of irrigated lesion formation with single fiber based multispectral system using machine learning.

Authors:  Soo Young Park; Rajinder P Singh-Moon; Haiqiu Yang; Christine P Hendon
Journal:  J Biophotonics       Date:  2022-06-15       Impact factor: 3.390

5.  Initial experience with total thoracoscopic ablation.

Authors:  Hee Moon Lee; Su Ryeun Chung; Dong Seop Jeong
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-02-05

Review 6.  Management strategies for atrial fibrillation.

Authors:  Peysh A Patel; Noman Ali; Andrew Hogarth; Muzahir H Tayebjee
Journal:  J R Soc Med       Date:  2017-01       Impact factor: 5.344

7.  Renal artery ablation instead of pulmonary vein ablation in a hypertensive patient with symptomatic, drug-resistant, persistent atrial fibrillation.

Authors:  Dirk Vollmann; Samuel Sossalla; Marco R Schroeter; Markus Zabel
Journal:  Clin Res Cardiol       Date:  2012-12-14       Impact factor: 5.460

Review 8.  Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.

Authors:  Jonathan Nyong; Guy Amit; Alma J Adler; Onikepe O Owolabi; Pablo Perel; David Prieto-Merino; Pier Lambiase; Juan Pablo Casas; Carlos A Morillo
Journal:  Cochrane Database Syst Rev       Date:  2016-11-22

9.  Costs and clinical consequences of suboptimal atrial fibrillation management.

Authors:  Steven N Singh
Journal:  Clinicoecon Outcomes Res       Date:  2012-03-26

10.  Patient preferences at ten years following initial diagnosis of atrial fibrillation: the Belgrade Atrial Fibrillation Study.

Authors:  Tatjana S Potpara; Marija M Polovina; Nebojsa M Mujovic; Aleksandar M Kocijancic; Gregory Yh Lip
Journal:  Patient Prefer Adherence       Date:  2013-08-26       Impact factor: 2.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.